Mohamed Y Ismail

age ~63

from Eden Prairie, MN

Get Report
Also known as:
  • Mohamed Yusuf Ismail
  • Mohamed Y Osmail
  • Mohammed Ismail
Related to:
Connected to:

Mohamed Ismail Phones & Addresses

  • Eden Prairie, MN
  • Wellesley, MA
  • Bedford, MA
  • Andover, MA

Us Patents

  • Substituted Tetracycline Compounds

    view source
  • US Patent:
    20170305840, Oct 26, 2017
  • Filed:
    Dec 9, 2016
  • Appl. No.:
    15/374329
  • Inventors:
    - Boston MA, US
    Kwasi Ohemeng - West Haven CT, US
    Paul Abato - Providence RI, US
    Victor Amoo - Daphne AL, US
    Haregewein Assefa - Braintree MA, US
    Joel Berniac - Stoneham MA, US
    Beena Bhatia - Mansfield MA, US
    Todd Bowser - Charlton MA, US
    Jackson Chen - East Amherst NY, US
    Mark Grier - Midvale UT, US
    Laura Honeyman - Etobicoke, CA
    Mohamed Y. Ismail - Eden Prairie MN, US
    Oak K. Kim - Cambridge MA, US
    Jude Mathews - Gloucester MA, US
    Rachid Mechiche - Boston MA, US
  • International Classification:
    C07C 237/48
    C07C 275/28
    C07C 271/54
    C07C 271/22
    C07C 275/30
    C07C 237/26
    C07C 2603/46
    A61K 31/65
    C07C 2601/14
    C07C 2601/16
    C07C 2601/02
  • Abstract:
    The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.

  • 11A, 12-Derivatives Of Tetracycline Compounds

    view source
  • US Patent:
    20160039749, Feb 11, 2016
  • Filed:
    May 23, 2013
  • Appl. No.:
    13/901525
  • Inventors:
    Joel Berniac - Stoneham MA, US
    Mohamed Y. Ismail - Bedford MA, US
    Mark L. Nelson - Norfolk MA, US
    Farzaneh Seyedi - Mansfield MA, US
  • International Classification:
    C07C 237/26
  • Abstract:
    11a,12-dehydrotetracycline compounds are described.

  • 3, 10, And 12A Substituted Tetracycline Compounds

    view source
  • US Patent:
    20160031802, Feb 4, 2016
  • Filed:
    Jul 8, 2013
  • Appl. No.:
    13/936941
  • Inventors:
    - Boston MA, US
    Jackson Chen - East Amherst NY, US
    Mohamed Y. Ismail - Bedford MA, US
    Mark L. Nelson - Norfolk MA, US
    Kwasi Ohemeng - Sakumono, GH
  • International Classification:
    C07C 237/26
    C07D 265/12
    C07D 317/54
  • Abstract:
    The present invention pertains to novel 3, 10, and/or 12a-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.

  • Substituted Tetracycline Compounds

    view source
  • US Patent:
    20150045329, Feb 12, 2015
  • Filed:
    May 19, 2014
  • Appl. No.:
    14/281357
  • Inventors:
    - Boston MA, US
    Kwasi Ohemeng - West Haven CT, US
    Paul Abato - Providence RI, US
    Victor Amoo - Daphne AL, US
    Haregewein Assefa - Braintree MA, US
    Joel Berniac - Stoneham MA, US
    Beena Bhatia - Mansfield MA, US
    Todd Bowser - Charlton MA, US
    Jackson Chen - East Amherst NY, US
    Mark Grier - Medford MA, US
    Laura Honeyman - Etobicoke, CA
    Mohamed Y. Ismail - Bedford MA, US
    Oak K. Kim - Cambridge MA, US
    Jude Mathews - Gloucester MA, US
    Rachid Mechiche - Boston MA, US
  • Assignee:
    Paratek Pharmaceuticals, Inc. - Boston MA
  • International Classification:
    C07C 237/48
  • US Classification:
    514152, 552205
  • Abstract:
    The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.

  • 9-Aminomethyl Substituted Minocycline Compounds

    view source
  • US Patent:
    20140309199, Oct 16, 2014
  • Filed:
    Jun 27, 2014
  • Appl. No.:
    14/318031
  • Inventors:
    - Boston MA, US
    Roger Frechette - Reading MA, US
    Mohamed Y. Ismail - Bedford MA, US
    Laura Honeyman - Etobicoke, CA
    Todd Bowser - Charlton MA, US
    Beena Bhatia - Mansfield MA, US
  • International Classification:
    C07C 237/26
  • US Classification:
    514152
  • Abstract:
    The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and minocycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.

  • Substituted Tetracycline Compounds

    view source
  • US Patent:
    20140155357, Jun 5, 2014
  • Filed:
    Jun 14, 2013
  • Appl. No.:
    13/918197
  • Inventors:
    Paul Abato - Providence RI, US
    Haregewein Assefa - Braintree MA, US
    Joel Berniac - Stoneham MA, US
    Beena Bhatia - Mansfield MA, US
    Todd Bowser - Charlton MA, US
    Jackson Chen - East Amherst NY, US
    Mark Grier - Medford MA, US
    Laura Honeyman - Roslindale MA, US
    Mohamed Y. Ismail - Bedford MA, US
    Mark L. Nelson - Norfolk MA, US
    Kwasi Ohemeng - Sakumono, GH
    Jingwen Pan - North Grafton MA, US
  • International Classification:
    C07D 471/04
    C07C 237/26
    C07D 277/30
    C07D 207/337
    C07D 213/73
    C07D 231/12
    C07D 211/70
    C07D 307/54
  • US Classification:
    514152, 546285, 546121, 564165, 549494, 548529, 546246, 5483771, 548204
  • Abstract:
    The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.

  • 9-Substituted Minocycline Compounds

    view source
  • US Patent:
    20120283201, Nov 8, 2012
  • Filed:
    Jul 12, 2012
  • Appl. No.:
    13/547870
  • Inventors:
    Mark L. Nelson - Norfolk MA, US
    Roger Frechette - Reading MA, US
    Peter Viski - Chestnut Hill MA, US
    Mohamed Y. Ismail - Bedford MA, US
    Todd Bowser - Charlton MA, US
    Jimmy Dumornay - Tampa FL, US
    Glen Rennie - South Weymouth MA, US
    Gui Liu - Lexington MA, US
    Darrell J. Koza - Willimantic CT, US
    Paul Sheahan - Hopkinton MA, US
    Karen Stapleton - Weymouth MA, US
    Paul Hawkins - Santa Fe NM, US
    Atul K. Verma - Mansfield MA, US
    Laura Honeyman - London, CA
    Tadeusz Warchol - Northborough MA, US
    David Messersmith - Somerville MA, US
  • Assignee:
    Trustees of Tufts College - Medford MA
    Paratek Pharmaceuticals, Inc. - Boston MA
  • International Classification:
    A61K 31/65
    C07C 275/40
    C07C 271/30
    C07D 307/81
    C07D 333/24
    C07D 317/60
    C07F 9/40
    A61K 31/662
    C07C 311/21
    C07C 255/60
    C07F 7/10
    A61K 31/695
    C07D 295/155
    C07C 275/54
    C07C 335/20
    C07C 311/05
    C07D 213/56
    C07C 279/18
    C07H 15/203
    A61K 31/7034
    A61P 31/04
    A61P 35/00
    C07D 213/64
    C07C 237/26
  • US Classification:
    514 25, 552205, 514152, 549469, 549 77, 549441, 514119, 514 63, 544380, 546285, 536 179
  • Abstract:
    The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.

  • 11A, 12-Derivatives Of Tetracycline Compounds

    view source
  • US Patent:
    20120101070, Apr 26, 2012
  • Filed:
    Dec 29, 2011
  • Appl. No.:
    13/340040
  • Inventors:
    Joel Berniac - Stoneham MA, US
    Mohamed Y. Ismail - Bedford MA, US
    Mark L. Nelson - Norfolk MA, US
    Faye Seyedi - Mansfield MA, US
  • Assignee:
    Paratek Pharmaceuticals, Inc. - Boston MA
  • International Classification:
    A61K 31/65
    A61P 25/28
    A61P 25/00
    C07C 237/26
    A61P 31/04
  • US Classification:
    514152, 552205
  • Abstract:
    11a,12-dehydrotetracycline compounds are described.

License Records

Mohamed Sara Ismail

License #:
019272
Category:
Registered Physician Assistant
Issued Date:
Oct 15, 2015
Type:
PHYSICIAN ASSISTANT
Get Report for Mohamed Y Ismail from Eden Prairie, MN, age ~63
Control profile